Prior judgement of what represents a 'significant' IGT, perhaps involving some consideration of the accompanying insulin response, might thus bias the composition and subsequent natural history of a group. Ethnic differences themselves may play a role; characteristics of Japanese IGT may differ from British or Indian. Nevertheless there is a strong prima facie case for proposing, that, until it is shown to be untrue, in an ethnic group perhaps, or in some other specific situation, that those with the degree of glucose intolerance specified as IGT behave differently as a group from those specified as DM. It would be most valuable to be able to distinguish subsets of IGT whose metabolic fate could be more accurately predicted; and if this were established, there would be a strong case for making a special category for them. Insulin responses would seem to be an attractive analytical characteristic but the evidence that low responses are predictive is not compelling. In normal population samples, insulin responses cover a very wide range (and are moderately variable from time to time in the same person). This range and variability are to be expected as a background in any collection of people distinguished by IGT and must be taken into consideration.
It is very much to be hoped that research such as that of Professor Kosaka and his colleagues will in due course, bring more light into our current confusions and make it possible to describe with much 9 greater precision the biochemical and endocrine basis of hyperglycaemia of all degrees, to predict its likely outcome and to indicate ways in which it may be improved. However, at present we cannot agree that the measurement of insulin plays a part in clinical diagnostic criteria for IGT or DM nor that knowledge of it has yet been shown to improve prediction as to outcome or to indicate more or less effective means of clinical management. 
